Whitepapers

Jan 12, 2015
The ability to capture, connect, and extract value from laboratory asset data is critical to a company's ability to run its business efficiently. Decision makers are hard pressed to answer fundamental questions about laboratory assets: asset census and density, laboratory service event information, instrument downtime and asset utilization. Given this reality, knowing what your optimized asset footprint should be, much less the real total cost of ownership is a challenge. "Bringing Business Analytics to the Lab" discusses overcoming these challenges.
Dec 19, 2014
This Improving Lab Efficiency Through New Mobility and Data Visualization Techniques whitepaper explores the impact of mobile applications and visualizing instrument performance using new techniques with the objective of creating a more interactive and informative lab environment.
Dec 19, 2014
Once brand teams are done with the tasks of selecting a copay vendor, figuring out budgets, and determining launch dates, they often feel that their work is done. Fortunately, the very nature of copay programs is quite forgiving so even an attitude of “benign neglect” may result in a successful and cost-effective program. However, the use of Analytics can substantially improve the likelihood that a program will be successful – if the right ones are used and if they’re used at the right times.
Dec 01, 2014
A reliable and properly documented cold chain is critically important for pharmaceutical manufacturers. Shipping a product improperly can harm the patient and can also harm a manufacturer’s reputation and bottom line. This whitepaper discusses the role of documentation, details how to protect products, and provides a cold chain shopping checklist.
Nov 18, 2014
By MDOL
The following interview on trends and the state of pharmaceutical marketing is with Jeff Meehan, Chief Commercial Offcer of MD On- Line, Inc. (MDOL), a provider of electronic healthcare solutions that leverage data to improve provider workfow and industry connectivity. But if you’re expecting to read something dry and techie, forget it. The prevalent message and overriding concern of Meehan’s is sensitivity—providing solutions that are responsive to both physicians’ practice and patients’ needs while creating value without increasing complexity. Whoever said technology didn’t have a soul?
Nov 12, 2014
This whitepaper helps healthcare marketers understand the time and information challenges of doctors today. It also outlines a simple way to better communicate with doctors, so they spend less time absorbing medical news and more time applying those insights to their patients.
Nov 01, 2014
The landscape in which drugs are named is increasingly complex due to rapid changes in technology, consumer expectations and market competition for trademarks. But one of the biggest factors affecting how companies now name their products is change in global regulations. In this paper, inVentiv Health’s Addison Whitney explores some of the factors companies must consider in naming a new product and describes a process for enhancing the likelihood of success.
Nov 01, 2014
The landscape in which drugs are named is increasingly complex due to rapid changes in technology, consumer expectations and market competition for trademarks. But one of the biggest factors affecting how companies now name their products is change in global regulations. In this paper, inVentiv Health’s Addison Whitney explores some of the factors companies must consider in naming a new product and describes a process for enhancing the likelihood of success.
Nov 01, 2014
Innovative patient pharmacology services is a unique scientific/medical and operational model that can be used to conduct studies in patients with hepatic impairment following the same guidelines used in traditional Phase I or Phase IIa trials. This approach has demonstrated proven advantages compared to the standard monitor-based site management model and results in the delivery of faster and better patient pharmacology data.
Oct 06, 2014
As Integrated Health Systems (IHSs) employ more physicians, individual providers are becoming less influential in decisions regarding prescribing and treatment, sales rep access, drug sample policies, and health IT adoption. Download this OneKey report to learn about the implications of the physician employment trend and how to achieve commercial success.